View in EDS

Bortezomib Followed by a Phase I Study of Bortezomib in Combination With High-Dose Melphalan as a Preparative Regimen for Hematopoietic Cell Transplants in Patients With Primary Refractory Multiple Myeloma or Plasma Cell Leukemia

Saved in:
Bibliographic Details
Title: Bortezomib Followed by a Phase I Study of Bortezomib in Combination With High-Dose Melphalan as a Preparative Regimen for Hematopoietic Cell Transplants in Patients With Primary Refractory Multiple Myeloma or Plasma Cell Leukemia
Authors: Nishihori, T.1,2, Alekshun, T.J.2, Sullivan, D.M.1,2, Kharfan-Dabaja, M.A.1,2, Raychaudhuri, J.1,2, Ochoa-Bayona, J.L.1,2, Shain, K.1,2, Yarde, D.N.1, Oliviera, V.1, Pidala, J.1,2, Fulp, W.1, Chen, D.-T.1, Kim, J.1, Simonelli, C.M.1, Maddox, B.1, Anasetti, C.1,2, Alsina, M.1,2
Source: Biology of Blood & Marrow Transplantation. Feb2011 Supplement, Vol. 17 Issue 2, pS200-S201. 0p.
Database: Academic Search Ultimate
Description
ISSN:10838791
DOI:10.1016/j.bbmt.2010.12.150